TENOFOVIR DF (TDF) FOR CHRONIC HEPATITIS B PATIENTS WITH SUBOPTIMAL RESPONSE TO ADEFOVIR (ADV) OR ADV/LAM TREATMENT: INTERIM ANALYSIS OF THE MULTICENTER PROSPECTIVE OPEN LABEL STUDY OPTIB

(1) Dept Internal Medicine, Sapienza University, Rome

(2) Gastroenterology Unit, University of Milan, Milan

(3) Dept Internal Medicine, University of Messina, Messina

(4) Dip di Malattie Infettive, Seconda Università di Napoli, Napoli

(5) Infectious Diseases, Osp San Sebastiano, Caserta

(6) Dep. Gastroenterology, Ospedale Molinette, Torino

(7) UO Gastroentrologia, Ospedali Riuniti, Bergamo

(8) UO Gastroentrologia, IRCCS, San Giovanni Rotondo

(9) Infectious Diseases, University of Bari, Bari

(10) UO Gastronterologia, University of Palermo, Palermo

(11) Dep. Internal Medicine and Gastroenterology, University of Bologna, Bologna

(12) UO Epatologia, Az Osp Cardarelli, Napoli

(13) Gastroenterologia, Universita' di Roma Tor Vergata, Rome, Italy



This item was part of the LIVER I session at Gastro 2009 UEGW/WCOG London (17th UEGW)

This item can be cited as: Gut 2009; 58 (Suppl II) A207